LBT INNOVATIONS LIMITED - Announcements

Market Cap $21.47M Add to my watchlist

Healthcare Medical Devices

LBT Innovations is a ground-breaking designer of advanced technology solutions for the... LBT Innovations is a ground-breaking designer of advanced technology solutions for the medical industry. We specialise in combining artificial intelligence, image analysis and software engineering to improve healthcare delivery. Our product, APAS® Independence, is a global first solution for automated reading of microbiology culture plates.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

LBT	Appendix 2A		04/08/20	523.84KB	Share
LBT	Appendix 4C - quarterly	PRICE SENSITIVE	29/07/20	378.29KB	Share
LBT	Share Purchase Plan		17/07/20	581.81KB	Share
LBT	Cleansing Notice - Notice Under Section 708A		16/07/20	102.87KB	Share
LBT	First Placement of APAS Independence in UK Lab		16/07/20	223.3KB	Share
LBT	Appendix 2A		15/07/20	275.12KB	Share
LBT	Oneservice Appointed Managed Service Provider for APAS	PRICE SENSITIVE	13/07/20	145.38KB	Share
LBT	Proposed issue of Securities - LBT	PRICE SENSITIVE	09/07/20	34.63KB	Share
LBT	$8M PRIVATE PLACEMENT & LAUNCH OF SPP	PRICE SENSITIVE	09/07/20	1.56MB	Share
LBT	Trading Halt	PRICE SENSITIVE	07/07/20	338.52KB	Share
LBT	Pause in Trading	PRICE SENSITIVE	07/07/20	115.04KB	Share
LBT	LBT TEAMS WITH GLOBAL CLINICAL DIAGNOSTICS COMPANY	PRICE SENSITIVE	07/07/20	316KB	Share
LBT	Results of Evaluation of APAS Independence by Johns Hopkins	PRICE SENSITIVE	30/06/20	451.88KB	Share
LBT	First Sale of APAS Independence in United States	PRICE SENSITIVE	09/06/20	135.7KB	Share
LBT	Employee Incentive Plan		05/06/20	143.35KB	Share
LBT	Update on MRSA Analysis Module US FDA Submission	PRICE SENSITIVE	04/06/20	164.71KB	Share
LBT	$1.5M Draw Down on South Australian Government Loan	PRICE SENSITIVE	26/05/20	145.68KB	Share
LBT	Presentation at Finance News Network Online Event		19/05/20	126.15KB	Share
LBT	South Australian Government Agree to Extend Loan Facility	PRICE SENSITIVE	08/05/20	131.29KB	Share
LBT	Presentation at NWR Virtual Small Cap Conference	PRICE SENSITIVE	30/04/20	1.42MB	Share
LBT	Appendix 4C - quarterly	PRICE SENSITIVE	28/04/20	343.93KB	Share
LBT	US FDA 510(k) Submission for MRSA Analysis Module	PRICE SENSITIVE	30/03/20	136.56KB	Share
LBT	VRE Analysis Module - Clinical Study Commenced	PRICE SENSITIVE	19/03/20	135.38KB	Share
LBT	Johns Hopkins Hosp to Present Study Data APAS Independence	PRICE SENSITIVE	12/03/20	155.67KB	Share
LBT	Half Yearly Report and Accounts	PRICE SENSITIVE	27/02/20	755.69KB	Share
LBT	Company Secretary Appointment/Resignation		10/02/20	126.66KB	Share
LBT	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/20	323.01KB	Share
LBT	LBT Receives $1.1 Million R&D Tax Incentive	PRICE SENSITIVE	22/01/20	101.73KB	Share
LBT	Presentation at Biotech Showcase Investor Conference	PRICE SENSITIVE	14/01/20	1.52MB	Share
LBT	Change of Director's Interest Notice		12/12/19	162.64KB	Share
LBT	Change of Director's Interest Notice		11/12/19	162.54KB	Share
LBT	Appendix 3B		10/12/19	400.03KB	Share
LBT	Appendix 3B		28/11/19	397.07KB	Share
LBT	Results of Meeting		27/11/19	108.11KB	Share
LBT	CEO Presentation - AGM 2019	PRICE SENSITIVE	27/11/19	1.42MB	Share
LBT	Chairman's Address to Shareholders	PRICE SENSITIVE	27/11/19	109.92KB	Share
LBT	Appendix 3B		14/11/19	361.84KB	Share
LBT	Presentation at Australia Biotech Invest & Partnering 2019		31/10/19	125.7KB	Share
LBT	Final Director's Interest Notice		30/10/19	131.77KB	Share
LBT	Non-Executive Director Retirement	PRICE SENSITIVE	30/10/19	128.69KB	Share
LBT	Appendix 4C - quarterly	PRICE SENSITIVE	25/10/19	298.57KB	Share
LBT	Notice of Annual General Meeting/Proxy Form		22/10/19	360.39KB	Share
LBT	First European Sale of APAS Independence	PRICE SENSITIVE	21/10/19	145.61KB	Share
LBT	LBT Presents at Australian Microcap Investment Conference		21/10/19	102.5KB	Share
LBT	Appendix 4G		30/09/19	271.86KB	Share
LBT	Corporate Governance Statement		30/09/19	252.44KB	Share
LBT	Annual Report to shareholders		30/09/19	3.38MB	Share
LBT	LBT Presents at ExchangeSA Conference in Adelaide	PRICE SENSITIVE	26/09/19	2.31MB	Share
LBT	MRSA Analysis Module CE Mark Registration	PRICE SENSITIVE	25/09/19	133.87KB	Share
LBT	European Union Regulatory Certification & MRSA Study Results	PRICE SENSITIVE	16/09/19	145.9KB	Share
LBT	LBT Presents at ASX Small & Microcap Conference		05/09/19	123.77KB	Share
LBT	Full Year Statutory Accounts		29/08/19	1.16MB	Share
LBT	Appendix 4E Full Year Report	PRICE SENSITIVE	29/08/19	141.14KB	Share
LBT	Change of Director's Interest Notice		07/08/19	148.65KB	Share
LBT	Appendix 4C - quarterly	PRICE SENSITIVE	29/07/19	291.44KB	Share
LBT	Timing of Quarterly Results & Investor Call		25/07/19	129.04KB	Share
LBT	Update on Distributor Appointments	PRICE SENSITIVE	22/07/19	140.02KB	Share
LBT	Share Trading Policy		28/06/19	208.17KB	Share
LBT	South Australian Government Loan $1.5M Drawdown	PRICE SENSITIVE	27/06/19	131.69KB	Share
LBT	First U.S. Clinical Data with APAS Presented at ASM Microbe	PRICE SENSITIVE	24/06/19	658.03KB	Share
LBT	US Market Update	PRICE SENSITIVE	19/06/19	132.39KB	Share
LBT	Notice under Section 708A		11/06/19	85.31KB	Share
LBT	Information Required Under ASX Listing Rule 3.10.5A	PRICE SENSITIVE	11/06/19	111.28KB	Share
LBT	Appendix 3B		11/06/19	409.2KB	Share
LBT	$5M Oversubscribed Private Placement	PRICE SENSITIVE	05/06/19	1.46MB	Share
LBT	Trading Halt	PRICE SENSITIVE	03/06/19	292.92KB	Share
LBT	APAS Independence Receives US FDA 510(k) Clearance	PRICE SENSITIVE	20/05/19	442.5KB	Share
LBT	Trading Halt	PRICE SENSITIVE	17/05/19	157.96KB	Share
LBT	AusMedtech & ANDHealth Conferences		15/05/19	130.08KB	Share
LBT	South Australian Government Loan - $1.0M Drawdown	PRICE SENSITIVE	09/05/19	130.71KB	Share
LBT	Business Update Presentation	PRICE SENSITIVE	30/04/19	2.58MB	Share
LBT	Appendix 4C - quarterly	PRICE SENSITIVE	29/04/19	289.35KB	Share
LBT	Timing of Quarterly Results & Investor Call		24/04/19	129.14KB	Share
LBT	APAS Independence MRSA Study Results Presented at ECCMID	PRICE SENSITIVE	15/04/19	296.45KB	Share
LBT	MRSA Analysis Module - Clinical Study Commenced	PRICE SENSITIVE	02/04/19	133.9KB	Share
LBT	Change of Director's Interest Notice		01/04/19	150.96KB	Share
LBT	Initial Director's Interest Notice		25/03/19	188.26KB	Share
LBT	Change of Director's Interest Notice		22/03/19	153.26KB	Share
LBT	Final Director's Interest Notice		04/03/19	136.89KB	Share
LBT	Change of Director's Interest Notice		04/03/19	147.76KB	Share
LBT	Non-Executive Director Changes		01/03/19	129.21KB	Share
LBT	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/19	707.66KB	Share
LBT	Details of Investor Call - 6 February 2019		05/02/19	125.08KB	Share
LBT	Initial Director's Interest Notice		04/02/19	176.32KB	Share
LBT	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/19	292.43KB	Share
LBT	Appointment US Based Non-Executive Director Simon Arkell		30/01/19	134.35KB	Share
LBT	US FDA 510k Submitted for APAS Independence	PRICE SENSITIVE	21/12/18	139.09KB	Share
LBT	LBT Receives $1.9 Million R&D Tax Incentive	PRICE SENSITIVE	20/12/18	102.45KB	Share
LBT	Expiration of Options		10/12/18	92.72KB	Share
LBT	LBT Presentation - 121 Tech Investment Conference, Singapore	PRICE SENSITIVE	03/12/18	1.99MB	Share
LBT	Expiration of Options		03/12/18	93.06KB	Share
LBT	Results of Meeting		28/11/18	100.83KB	Share
LBT	CEO Presentation - AGM 2018	PRICE SENSITIVE	28/11/18	1.62MB	Share
LBT	Chairman's Address to Shareholders	PRICE SENSITIVE	28/11/18	94.4KB	Share
LBT	First Placement of APAS Independence into US Lab	PRICE SENSITIVE	26/11/18	123.82KB	Share
LBT	Australian Sales Update	PRICE SENSITIVE	26/11/18	118.52KB	Share
LBT	Quarterly Activities & Cashflow Report - Appendix 4C	PRICE SENSITIVE	31/10/18	410.92KB	Share
LBT	Notice of Annual General Meeting/Proxy Form		26/10/18	487.77KB	Share
LBT	Final Director's Interest Notice		23/10/18	216.2KB	Share
LBT	Change of Director's Interest Notice		23/10/18	168.42KB	Share

LBT Appendix 2A
04/08/20		523.84KB	Share
LBT Appendix 4C - quarterly
29/07/20	PRICE SENSITIVE	378.29KB	Share
LBT Share Purchase Plan
17/07/20		581.81KB	Share
LBT Cleansing Notice - Notice Under Section 708A
16/07/20		102.87KB	Share
LBT First Placement of APAS Independence in UK Lab
16/07/20		223.3KB	Share
LBT Appendix 2A
15/07/20		275.12KB	Share
LBT Oneservice Appointed Managed Service Provider for APAS
13/07/20	PRICE SENSITIVE	145.38KB	Share
LBT Proposed issue of Securities - LBT
09/07/20	PRICE SENSITIVE	34.63KB	Share
LBT $8M PRIVATE PLACEMENT & LAUNCH OF SPP
09/07/20	PRICE SENSITIVE	1.56MB	Share
LBT Trading Halt
07/07/20	PRICE SENSITIVE	338.52KB	Share
LBT Pause in Trading
07/07/20	PRICE SENSITIVE	115.04KB	Share
LBT LBT TEAMS WITH GLOBAL CLINICAL DIAGNOSTICS COMPANY
07/07/20	PRICE SENSITIVE	316KB	Share
LBT Results of Evaluation of APAS Independence by Johns Hopkins
30/06/20	PRICE SENSITIVE	451.88KB	Share
LBT First Sale of APAS Independence in United States
09/06/20	PRICE SENSITIVE	135.7KB	Share
LBT Employee Incentive Plan
05/06/20		143.35KB	Share
LBT Update on MRSA Analysis Module US FDA Submission
04/06/20	PRICE SENSITIVE	164.71KB	Share
LBT $1.5M Draw Down on South Australian Government Loan
26/05/20	PRICE SENSITIVE	145.68KB	Share
LBT Presentation at Finance News Network Online Event
19/05/20		126.15KB	Share
LBT South Australian Government Agree to Extend Loan Facility
08/05/20	PRICE SENSITIVE	131.29KB	Share
LBT Presentation at NWR Virtual Small Cap Conference
30/04/20	PRICE SENSITIVE	1.42MB	Share
LBT Appendix 4C - quarterly
28/04/20	PRICE SENSITIVE	343.93KB	Share
LBT US FDA 510(k) Submission for MRSA Analysis Module
30/03/20	PRICE SENSITIVE	136.56KB	Share
LBT VRE Analysis Module - Clinical Study Commenced
19/03/20	PRICE SENSITIVE	135.38KB	Share
LBT Johns Hopkins Hosp to Present Study Data APAS Independence
12/03/20	PRICE SENSITIVE	155.67KB	Share
LBT Half Yearly Report and Accounts
27/02/20	PRICE SENSITIVE	755.69KB	Share
LBT Company Secretary Appointment/Resignation
10/02/20		126.66KB	Share
LBT Appendix 4C - quarterly
30/01/20	PRICE SENSITIVE	323.01KB	Share
LBT LBT Receives $1.1 Million R&D Tax Incentive
22/01/20	PRICE SENSITIVE	101.73KB	Share
LBT Presentation at Biotech Showcase Investor Conference
14/01/20	PRICE SENSITIVE	1.52MB	Share
LBT Change of Director's Interest Notice
12/12/19		162.64KB	Share
LBT Change of Director's Interest Notice
11/12/19		162.54KB	Share
LBT Appendix 3B
10/12/19		400.03KB	Share
LBT Appendix 3B
28/11/19		397.07KB	Share
LBT Results of Meeting
27/11/19		108.11KB	Share
LBT CEO Presentation - AGM 2019
27/11/19	PRICE SENSITIVE	1.42MB	Share
LBT Chairman's Address to Shareholders
27/11/19	PRICE SENSITIVE	109.92KB	Share
LBT Appendix 3B
14/11/19		361.84KB	Share
LBT Presentation at Australia Biotech Invest & Partnering 2019
31/10/19		125.7KB	Share
LBT Final Director's Interest Notice
30/10/19		131.77KB	Share
LBT Non-Executive Director Retirement
30/10/19	PRICE SENSITIVE	128.69KB	Share
LBT Appendix 4C - quarterly
25/10/19	PRICE SENSITIVE	298.57KB	Share
LBT Notice of Annual General Meeting/Proxy Form
22/10/19		360.39KB	Share
LBT First European Sale of APAS Independence
21/10/19	PRICE SENSITIVE	145.61KB	Share
LBT LBT Presents at Australian Microcap Investment Conference
21/10/19		102.5KB	Share
LBT Appendix 4G
30/09/19		271.86KB	Share
LBT Corporate Governance Statement
30/09/19		252.44KB	Share
LBT Annual Report to shareholders
30/09/19		3.38MB	Share
LBT LBT Presents at ExchangeSA Conference in Adelaide
26/09/19	PRICE SENSITIVE	2.31MB	Share
LBT MRSA Analysis Module CE Mark Registration
25/09/19	PRICE SENSITIVE	133.87KB	Share
LBT European Union Regulatory Certification & MRSA Study Results
16/09/19	PRICE SENSITIVE	145.9KB	Share
LBT LBT Presents at ASX Small & Microcap Conference
05/09/19		123.77KB	Share
LBT Full Year Statutory Accounts
29/08/19		1.16MB	Share
LBT Appendix 4E Full Year Report
29/08/19	PRICE SENSITIVE	141.14KB	Share
LBT Change of Director's Interest Notice
07/08/19		148.65KB	Share
LBT Appendix 4C - quarterly
29/07/19	PRICE SENSITIVE	291.44KB	Share
LBT Timing of Quarterly Results & Investor Call
25/07/19		129.04KB	Share
LBT Update on Distributor Appointments
22/07/19	PRICE SENSITIVE	140.02KB	Share
LBT Share Trading Policy
28/06/19		208.17KB	Share
LBT South Australian Government Loan $1.5M Drawdown
27/06/19	PRICE SENSITIVE	131.69KB	Share
LBT First U.S. Clinical Data with APAS Presented at ASM Microbe
24/06/19	PRICE SENSITIVE	658.03KB	Share
LBT US Market Update
19/06/19	PRICE SENSITIVE	132.39KB	Share
LBT Notice under Section 708A
11/06/19		85.31KB	Share
LBT Information Required Under ASX Listing Rule 3.10.5A
11/06/19	PRICE SENSITIVE	111.28KB	Share
LBT Appendix 3B
11/06/19		409.2KB	Share
LBT $5M Oversubscribed Private Placement
05/06/19	PRICE SENSITIVE	1.46MB	Share
LBT Trading Halt
03/06/19	PRICE SENSITIVE	292.92KB	Share
LBT APAS Independence Receives US FDA 510(k) Clearance
20/05/19	PRICE SENSITIVE	442.5KB	Share
LBT Trading Halt
17/05/19	PRICE SENSITIVE	157.96KB	Share
LBT AusMedtech & ANDHealth Conferences
15/05/19		130.08KB	Share
LBT South Australian Government Loan - $1.0M Drawdown
09/05/19	PRICE SENSITIVE	130.71KB	Share
LBT Business Update Presentation
30/04/19	PRICE SENSITIVE	2.58MB	Share
LBT Appendix 4C - quarterly
29/04/19	PRICE SENSITIVE	289.35KB	Share
LBT Timing of Quarterly Results & Investor Call
24/04/19		129.14KB	Share
LBT APAS Independence MRSA Study Results Presented at ECCMID
15/04/19	PRICE SENSITIVE	296.45KB	Share
LBT MRSA Analysis Module - Clinical Study Commenced
02/04/19	PRICE SENSITIVE	133.9KB	Share
LBT Change of Director's Interest Notice
01/04/19		150.96KB	Share
LBT Initial Director's Interest Notice
25/03/19		188.26KB	Share
LBT Change of Director's Interest Notice
22/03/19		153.26KB	Share
LBT Final Director's Interest Notice
04/03/19		136.89KB	Share
LBT Change of Director's Interest Notice
04/03/19		147.76KB	Share
LBT Non-Executive Director Changes
01/03/19		129.21KB	Share
LBT Half Yearly Report and Accounts
26/02/19	PRICE SENSITIVE	707.66KB	Share
LBT Details of Investor Call - 6 February 2019
05/02/19		125.08KB	Share
LBT Initial Director's Interest Notice
04/02/19		176.32KB	Share
LBT Appendix 4C - quarterly
31/01/19	PRICE SENSITIVE	292.43KB	Share
LBT Appointment US Based Non-Executive Director Simon Arkell
30/01/19		134.35KB	Share
LBT US FDA 510k Submitted for APAS Independence
21/12/18	PRICE SENSITIVE	139.09KB	Share
LBT LBT Receives $1.9 Million R&D Tax Incentive
20/12/18	PRICE SENSITIVE	102.45KB	Share
LBT Expiration of Options
10/12/18		92.72KB	Share
LBT LBT Presentation - 121 Tech Investment Conference, Singapore
03/12/18	PRICE SENSITIVE	1.99MB	Share
LBT Expiration of Options
03/12/18		93.06KB	Share
LBT Results of Meeting
28/11/18		100.83KB	Share
LBT CEO Presentation - AGM 2018
28/11/18	PRICE SENSITIVE	1.62MB	Share
LBT Chairman's Address to Shareholders
28/11/18	PRICE SENSITIVE	94.4KB	Share
LBT First Placement of APAS Independence into US Lab
26/11/18	PRICE SENSITIVE	123.82KB	Share
LBT Australian Sales Update
26/11/18	PRICE SENSITIVE	118.52KB	Share
LBT Quarterly Activities & Cashflow Report - Appendix 4C
31/10/18	PRICE SENSITIVE	410.92KB	Share
LBT Notice of Annual General Meeting/Proxy Form
26/10/18		487.77KB	Share
LBT Final Director's Interest Notice
23/10/18		216.2KB	Share
LBT Change of Director's Interest Notice
23/10/18		168.42KB	Share

REFRESH

First 2 3 4 5 6

(20min delay)
Last 1.3¢		Change -0.001(7.14%)		Mkt cap ! $21.47M

Open	High	Low	Value	Volume
1.4¢	1.4¢	1.3¢	$12.8K	950K

Buyers (Bids)

No.	Vol.	Price($)
6	4268596	1.3¢

Sellers (Offers)

Price($)	Vol.	No.
1.4¢	197886	2

View Market Depth

No.	Vol.	Price($)
5	4245520	0.013
3	7333332	0.012
6	806500	0.011
5	1089004	0.010
3	256759	0.009

Price($)	Vol.	No.
0.015	429699	3
0.016	931586	6
0.017	990881	7
0.018	457000	3
0.020	115000	1

Last trade - 14.43pm 20/09/2024 (20 minute delay)


Last 1.3¢		Change -0.001 ( 3.70 %)
Open	High	Low	Volume
1.5¢	1.5¢	1.3¢	662691
Last updated 15.59pm 20/09/2024 ?

LBT (ASX) Chart

LBT INNOVATIONS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available